BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 45 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,611,000 | -70.4% | 4,500,000 | -70.0% | 0.02% | -70.6% |
| Q2 2021 | $15,566,000 | +1.7% | 15,000,000 | 0.0% | 0.07% | +3.0% |
| Q1 2021 | $15,299,000 | -4.6% | 15,000,000 | 0.0% | 0.07% | +10.0% |
| Q4 2020 | $16,033,000 | +2.4% | 15,000,000 | 0.0% | 0.06% | -4.8% |
| Q3 2020 | $15,650,000 | -14.7% | 15,000,000 | 0.0% | 0.06% | -22.2% |
| Q2 2020 | $18,340,000 | +17.7% | 15,000,000 | 0.0% | 0.08% | -15.6% |
| Q1 2020 | $15,576,000 | -1.7% | 15,000,000 | 0.0% | 0.10% | +14.3% |
| Q4 2019 | $15,841,000 | +7.6% | 15,000,000 | 0.0% | 0.08% | -16.0% |
| Q3 2019 | $14,722,000 | -5.4% | 15,000,000 | 0.0% | 0.10% | -5.7% |
| Q2 2019 | $15,566,000 | +1.2% | 15,000,000 | 0.0% | 0.11% | +8.2% |
| Q1 2019 | $15,385,000 | +3.2% | 15,000,000 | 0.0% | 0.10% | -19.7% |
| Q4 2018 | $14,911,000 | -5.7% | 15,000,000 | 0.0% | 0.12% | +17.3% |
| Q3 2018 | $15,818,000 | +4.1% | 15,000,000 | 0.0% | 0.10% | -8.8% |
| Q2 2018 | $15,198,000 | +7.8% | 15,000,000 | 0.0% | 0.11% | -5.0% |
| Q1 2018 | $14,099,000 | -5.6% | 15,000,000 | 0.0% | 0.12% | -7.0% |
| Q4 2017 | $14,928,000 | -1.7% | 15,000,000 | 0.0% | 0.13% | +4.9% |
| Q3 2017 | $15,193,000 | – | 15,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 19,413,000 | $19,245,611 | 1.50% |
| SSI INVESTMENT MANAGEMENT LLC | 9,386,000 | $9,219,566 | 0.65% |
| PFM Health Sciences, LP | 15,000,000 | $14,771,520 | 0.57% |
| RWC Asset Management LLP | 11,000,000 | $10,848,475 | 0.52% |
| Sonora Investment Management Group, LLC | 6,280,000 | $6,184,858 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 24,020,000 | $23,654,128 | 0.46% |
| Lombard Odier Asset Management (Europe) Ltd | 7,224,000 | $7,124,489 | 0.34% |
| MACKAY SHIELDS LLC | 10,123,000 | $9,943,520 | 0.28% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,478,000 | $9,323,983 | 0.25% |
| Nicholas Investment Partners, LP | 2,940,000 | $2,887,868 | 0.20% |